Bio-Rad Offers a Range of Anti-Daratumumab Antibodies Specific for Daratumumab

Bio-Rad has launched a range of antibodies specifically for daratumumab that inhibit the binding of the drug to the target antigen, CD38, which allows for highly specific bioanalysis and drug monitoring.